NEUGENESIS CORP has a total of 17 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are AVARIS AB, AMVAC AG and ADMEDUS VACCINES PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Combinatorial chemistry | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Cambareri Edward B | 9 |
#2 | Stuart W Dorsey | 7 |
#3 | Kato Eli E | 4 |
#4 | Parish John Howard | 3 |
#5 | Radford Alan | 3 |
#6 | Stuart Dorsey W | 2 |
#7 | Stuart Dorsey W Cambareri Edwa | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006044796A2 | Methods and compositions for combinatoral-based production of multivalent recombinant antigens | |
WO0170946A2 | Methods for in vivo diversification of single genes | |
EP1177282A1 | Combinatorial metabolic libraries |